Detalhe da pesquisa
1.
Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-19.
N Engl J Med
; 390(13): 1186-1195, 2024 Apr 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38598573
2.
Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid-19.
N Engl J Med
; 386(15): 1397-1408, 2022 04 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35172054
3.
Summary of the safety and tolerability of two treatment regimens of ceftaroline fosamil: 600 mg every 8 h versus 600 mg every 12 h.
J Antimicrob Chemother
; 74(4): 1086-1091, 2019 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30597021
4.
Oral gemifloxacin versus sequential therapy with intravenous ceftriaxone/oral cefuroxime with or without a macrolide in the treatment of patients hospitalized with community-acquired pneumonia: a randomized, open-label, multicenter study of clinical efficacy and tolerability.
Clin Ther
; 24(11): 1915-36, 2002 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-12501883
5.
Results of a double-blind, randomized trial of ceftobiprole treatment of complicated skin and skin structure infections caused by gram-positive bacteria.
Antimicrob Agents Chemother
; 52(1): 37-44, 2008 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-17954698
6.
Probability of target attainment for ceftobiprole as derived from a population pharmacokinetic analysis of 150 subjects.
Antimicrob Agents Chemother
; 51(7): 2378-87, 2007 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-17387149
7.
Augmentin (amoxicillin/clavulanate) in the treatment of community-acquired respiratory tract infection: a review of the continuing development of an innovative antimicrobial agent.
J Antimicrob Chemother
; 53 Suppl 1: i3-20, 2004 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-14726431